Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Testosterone is crucial for development, growth, and various body functions in mammals.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

PSA can help diagnose high androgen levels in women.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Androgens can both increase and decrease hair growth in different parts of the body.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Men with Kennedy disease have less chance of hair loss.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.